These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group. Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027 [Abstract] [Full Text] [Related]
7. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Siener R, Ebert D, Nicolay C, Hesse A. Kidney Int; 2003 Mar 07; 63(3):1037-43. PubMed ID: 12631085 [Abstract] [Full Text] [Related]
8. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. J Am Soc Nephrol; 1999 Nov 07; 10 Suppl 14():S329-33. PubMed ID: 10541257 [Abstract] [Full Text] [Related]
9. Evidence of increased oxalate absorption in patients with calcium-containing renal stones. Hodgkinson A. Clin Sci Mol Med; 1978 Mar 07; 54(3):291-4. PubMed ID: 630804 [Abstract] [Full Text] [Related]
10. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption. Lindsjö M. Scand J Urol Nephrol Suppl; 1989 Mar 07; 119():1-53. PubMed ID: 2669121 [Abstract] [Full Text] [Related]
11. Oxalate synthesis, transport and the hyperoxaluric syndromes. Williams HE, Wandzilak TR. J Urol; 1989 Mar 07; 141(3 Pt 2):742-9. PubMed ID: 2645433 [Abstract] [Full Text] [Related]
13. The urinary response to an oral oxalate load in recurrent calcium stone formers. Krishnamurthy MS, Hruska KA, Chandhoke PS. J Urol; 2003 Jun 07; 169(6):2030-3. PubMed ID: 12771711 [Abstract] [Full Text] [Related]
15. Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers. Zhang J, Kumar S, Jayachandran M, Herrera Hernandez LP, Wang S, Wilson EM, Lieske JC. BMC Nephrol; 2021 Jun 01; 22(1):204. PubMed ID: 34074247 [Abstract] [Full Text] [Related]
16. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. Schwille PO, Hanisch E, Scholz D. J Urol; 1984 Oct 01; 132(4):650-5. PubMed ID: 6471206 [Abstract] [Full Text] [Related]
17. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP. Br J Urol; 1991 Nov 01; 68(5):454-8. PubMed ID: 1747716 [Abstract] [Full Text] [Related]
18. Oxalate status in stone-formers. Two distinct hyperoxaluric entities. Hatch M. Urol Res; 1993 Jan 01; 21(1):55-9. PubMed ID: 8456539 [Abstract] [Full Text] [Related]